Aandelen in “Productie van medische instrumenten”

Aandeel Datum Koers Evolutie
vlag Lantheus Holdings Inc 17/03 80,450 USD
+2,48% 		+2,48%
vlag Lemaitre Vascular Inc 17/03 112,230 USD
+1,34% 		+1,34%
vlag LENSAR Inc 16/03 10,260 USD
+4,16% 		+4,16%
vlag LivaNova PLC 17/03 62,430 USD
+1,63% 		+1,63%
vlag Lyra Therapeutics Inc 16/03 0,495 USD
-62,50% 		-62,50%

Nieuws over “Productie van medische instrumenten”

14/03 · Soleno Therapeutics, Inc. (SLNO) Securities Fraud Class Action Lawsuit Filed; May 5, 2026, Lead Plaintiff Deadline · Persbericht

14/03 · Soleno Therapeutics, Inc. (SLNO) Securities Fraud Class Action Lawsuit Filed; May 5, 2026, Lead Plaintiff Deadline · Persbericht

14/03 · Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline · Persbericht

12/03 · Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman · Persbericht

12/03 · Are JHG, UDMY, FONR Obtaining Fair Deals for their Shareholders? · Persbericht

12/03 · INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit · Persbericht

12/03 · BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 · Persbericht

12/03 · Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 · Persbericht

12/03 · BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt · Persbericht

12/03 · SLNO Lawsuit Alleges Allegedly Conducting Sham Clinical Trials - Soleno Therapeutics, Inc. Investors Face Losses Following Allegedly Conducting Sham Clinical Trials: SueWallSt · Persbericht

12/03 · Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies · Persbericht

12/03 · Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference · Persbericht

11/03 · GUERBET : Change in Guerbet’s Board of Directors. · Persbericht

11/03 · GUERBET : 2025 full-year results. · Persbericht

11/03 · SLNO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 · Persbericht

11/03 · DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 · Persbericht

10/03 · Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman · Persbericht

10/03 · Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health · Persbericht

10/03 · Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care · Persbericht

9/03 · Stryker launches SmartHospital Platform · Persbericht

6/03 · Are WBS, KW, TPH, FONR Obtaining Fair Deals for their Shareholders? · Persbericht

Mijn selecties